Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Octogenarians are not too old for cancer surgery

28.11.2006
Mayo Clinic Cancer Center finds age not automatic barrier to men with prostate cancer

Mayo Clinic Cancer Center researchers have found that a radical prostatectomy can be a viable option for select octogenarian patients. The findings, which run counter the conventional practice of generally avoiding surgeries for individuals over 80 years old solely based on age, are available today in Urology.

“Increased life expectancy and generally higher levels of wellness, as well as safer forms of anesthesia and less-invasive surgical techniques, have made it possible for older adults to safely and effectively have surgeries traditionally not offered over a certain age,” says Michael Lieber, M.D., Mayo Clinic urologist and the study’s senior investigator. “We didn’t think that using age as the deciding factor was a valid argument for not performing a radical prostatectomy, and we proved that it is a safe option for some men.”

One in six men will eventually be diagnosed with prostate cancer, reports the American Cancer Society, and more than 27,000 men will die from prostate cancer this year in the United States. A variety of treatment options exist for this traditionally slow-growing cancer, including hormone therapy, chemotherapy, radiation therapy, cryotherapy, surgery and expectant management (“watchful waiting”). JAMA reported in 2000 that urologists typically offer a radical prostatectomy to patients with more than 10 years of life expectancy, and do not offer this surgical option to patients older than age 70 to 75. Another study, published in The New England Journal of Medicine in 2005, showed that radical prostatectomy significantly reduces overall mortality, local disease progression, and distant metastases; and is associated with less hormone treatment and palliative radiation.

In the Mayo study, Dr. Lieber’s team reviewed records for the 19 patients age 80 or older who underwent radical prostatectomy at Mayo Clinic from 1986 to 2003. They found that while reasons for the radical prostatectomy varied, usually the patients requested or even demanded the surgery. At the time of surgery, the average patient age was 81 (range was 80 to 84), the average prostate-specific antigen (PSA) level was 10.2 nanograms per milliliter (normal is 0 to 4 ng/ml), and the average American Society of Anesthesiologists score (relates general health and risk of death) was 2.4 out of five (worst).

Thirteen had pathological stage pT3 (pT4 being the worst) disease or a Gleason score (tumor aggressiveness measurement system) of seven or more (out of 10). “These were patients with very aggressive forms of prostate cancer,” says R. Houston Thompson, M.D., the study’s primary author. “Had our surgeons not removed the cancer, risk of death or need for palliative care (radiation, hormones, etc.) certainly could have become an issue.”

The researchers say the decision to perform a radical prostatectomy for each man was reasonable, and the data agree. Of the 19 patients, 14 remained continent, none died within a year of surgery or from prostate cancer, and the 10-year survival rate was similar to that observed in healthy patients 60 to 79 years old undergoing a radical prostatectomy. Only three of the 19 died from any cause within 10 years of the surgery.

“Aging is a highly individualized process,” says Dr. Lieber. “Decisions should be made on a case-by-case basis, but we feel surgery can be offered to very healthy, active octogenarians with localized prostate cancer with satisfactory results.”

Elizabeth Zimmermann | EurekAlert!
Further information:
http://www.mayoclinic.com

More articles from Health and Medicine:

nachricht Penn studies find promise for innovations in liquid biopsies
30.03.2017 | University of Pennsylvania School of Medicine

nachricht 'On-off switch' brings researchers a step closer to potential HIV vaccine
30.03.2017 | University of Nebraska-Lincoln

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

'On-off switch' brings researchers a step closer to potential HIV vaccine

30.03.2017 | Health and Medicine

Penn studies find promise for innovations in liquid biopsies

30.03.2017 | Health and Medicine

An LED-based device for imaging radiation induced skin damage

30.03.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>